Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DepoCyt

Known as: Depo-Cyt, DepoFoam Encapsulated Cytarabine 
 
National Institutes of Health

Related topics

Related topics

2 relations
CytarabineCytarabine liposome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty.
Pain following orthopedic surgery is common and often suboptimally managed, with many patients reporting acute moderate to severe… Expand
Highly Cited
2012
Highly Cited
2012
Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series
Treatment of leptomeningeal metastasis (LMD) remains challenging due to advanced systemic disease at presentation and limited… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2006
Highly Cited
2006
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt®) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase…
SummaryIntroductionCytarabine liposome injection (DepoCyt®), a sterile suspension of the antimetabolite cytarabine, encapsulated… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Review
2006
Review
2006
Pharmacology of Drugs Formulated with DepoFoam™
Lamellar liposome technology has been used for several decades to produce sustained-release drug formulations for parenteral… Expand
Highly Cited
2004
Highly Cited
2004
An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis
Drugs currently available for intrathecal administration are cleared rapidly from the CSF. DepoCyt is a slow-release formulation… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2004
Highly Cited
2004
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
PURPOSE We performed a phase I trial of intrathecal (IT) liposomal cytarabine (DepoCyt; Enzon Pharmaceuticals, Piscataway, NJ and… Expand
2003
2003
Drug delivery systems in cancer therapy
Part I: Pharmacological Considerations for Drug Delivery Systems in Cancer Medicine Systemically Administered Drugs Reginald B… Expand
2003
2003
DEVELOPMENT OF A DEPOFOAM TECHNOLOGY FOR THE SUSTAINED DELIVERY OF DESFERRIOXAMINE MESYLATE
Encapsulation of drugs into multivesicular liposomes (Depofoam) offers a novel approach to sustained release drug delivery… Expand
  • figure 2
  • figure 1
  • table 1
Highly Cited
1999
Highly Cited
1999
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Standard treatment for neoplastic meningitis requires frequent intrathecal (IT) injections of chemotherapy and is only modestly… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Highly Cited
1999
Highly Cited
1999
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
PURPOSE To evaluate the efficacy and safety of a slow-release formulation of cytarabine (DepoCyt; Chiron Corp, Emeryville, CA… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE